Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 28;14(1):30781.
doi: 10.1038/s41598-024-80851-y.

Genetic epidemiology of amyotrophic lateral sclerosis in Cyprus: a population-based study

Ellie Mitsi  1   2   3 , Christina Votsi  1   3 , Pantelitsa Koutsou  1   3 , Anthi Georghiou  1   3 , Christiana C Christodoulou  2   3 , Kleopas Kleopa  4   5   3 , Eleni Zamba-Papanicolaou  2   3 , Kyproula Christodoulou  1   3 , Paschalis Nicolaou  6   7
Affiliations

Genetic epidemiology of amyotrophic lateral sclerosis in Cyprus: a population-based study

Ellie Mitsi et al. Sci Rep. .

Abstract

Amyotrophic lateral sclerosis (ALS) is a devastating, uniformly lethal degenerative disease of motor neurons, presenting with relentlessly progressive muscle atrophy and weakness. More than fifty genes carrying causative or disease-modifying variants have been identified since the 1990s, when the first ALS-associated variant in the gene SOD1 was discovered. The most commonly mutated ALS genes in the European populations include the C9orf72, SOD1, TARDBP and FUS. Understanding the genetic causes of ALS within a population is becoming more significant, especially in light of the possible development of personalized medicine. Here, we provide clinical and genetic data on familial and sporadic ALS patients in a Greek-Cypriot population-based cohort. Eighty-nine ALS patients, including 21 familial ALS (fALS) (23.6%) and 68 sporadic ALS (sALS) (76.4%), provided the cohort for variant screening of the most common ALS-associated genes. Moreover, next-generation sequencing (NGS) was also performed to identify rare ALS variants, and in silico prediction tools were applied to predict the downstream effect of the variants detected in our study. The pathogenic hexanucleotide G4C2 repeat expansion in C9orf72 was the predominant genetic cause (22.47%) of ALS in our population, while variants in six additional ALS-associated genes were identified, including ALS2, TARDBP, FIG4, TBK1, GLT8D1, and BICD2.

Keywords: Amyotrophic lateral sclerosis; Cyprus; Epidemiology; Genetics; Population-based study.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests. Study approval statement: The study was reviewed and ethically approved by the Cyprus National Bioethics Committee (EEBK/EΠ/2013/28) and conducted in accordance with the Declaration of Helsinki. Consent to participate: A written informed consent was obtained from participants. For deceased patients, information was collected from their next of kin, if possible.

Figures

Fig. 1
Fig. 1
Summary of genetic findings among familial and sporadic ALS patients in Cyprus.
Fig. 2
Fig. 2
Flow chart of the procedures for genetic screening in the cohort ALS population.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Goetz, C. Amyotrophic lateral sclerosis: Early contributions of muscle nerve. 23(March), 336–343 (2000). - PubMed
    1. Rowland, L. & Shneider, N. The clinical diagnosis of ALS is probably correct in more than 95% of cases. Engl. J.344 (22), 1688–1700 (2001). - PubMed
    1. Longinetti, E. & Fang, F. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr. Opin. Neurol.32 (5), 771–776 (2019). - PMC - PubMed
    1. Zhou, S. et al. Amyotrophic lateral sclerosis in Beijing: epidemiologic features and prognosis from 2010 to 2015. Brain Behav.8 (11), 1–7 (2018). - PMC - PubMed
    1. Leighton, D. J. et al. Changing epidemiology of motor neurone disease in Scotland. J. Neurol.266(4), 817–25. 10.1007/s00415-019-09190-7 (2019). - PubMed

Grants and funding